US20090014017A1 - Smoker's requisite

Info

Abstract

Description

Claims

US20090014017A1

Publication number: US20090014017A1
Application number: US12/003,068
Authority: US
Inventors: George Frederick Enslin
Original assignee: Individual
Current assignee: Individual
Priority date: 2001-04-09
Filing date: 2007-12-19
Publication date: 2009-01-15
Also published as: WO2002080708A3; US20040112395A1; US7325548B2; EP1411783A2; WO2002080708A2

A smoker's requisite embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof. The substance is embodied in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.

THIS INVENTION relates to a smoker's requisite.
For the purposes of tis specification, a “smoker's requisite should be understood to mean a device such as a cigarette or pipe which is lit and smoked by a smoker and accordingly includes, without being limited thereto, plain and filter cigarettes, pipes, cigars, cheroots and the like and the term further includes within the scope of its meaning a “smoking accessory” by which is meant an object or device which is used together with a cigarette, pipe, cigar, cheroot or the like such as a filter, cigarette holder, cigar holder or the like.
According to a first aspect of the invention there is provided a smoker's requisite which embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, the substance being embodied in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.
The substance or composition may be embodied in a component from which a smoker's requisite is made.
For example, it may be mixed with or impregnated into the tobacco of the smoker's requisite such as a cigarette or cigar prior to the manufacture of the requisite. It may be mixed with or impregnated into pipe tobacco or chewing tobacco. The substance may be crystallized or ground into powder, dissolved or liquified prior to being mixed with or impregnated into the tobacco. A portion of a plant or a substance of the invention may be desiccated, ground, shredded or reduced to smaller particles and these particles may be incorporated into the requisite. Instead, the substance or composition may be impregnated into the paper of a cigarette or into a filter of a cigarette, cigar, pipe or the like.
The tobacco, filter or cigarette paper may be impregnated with the substance or composition by methods such as applying the substance in liquid form to the tobacco, filter or cigarette paper, by immersing the tobacco, filter, or cigarette paper in a solution of the substance, impregnating by pressure, chemically impregnating, using an adhesive, saturation, gaseous infusion, immersion, spraying, radiation, osmosis, friction, mixing, blending, infusion, coating or waxing. The substance or composition may be carried or cased in animal or plant fats or modifications of them such as tallow, palm butter, cocoa butter, synthetic fats, saccharides such as lactose, glucose or mannose or in polymers or polymeric substances such as gelatine, cellulose, polyethyleneglycol and polyvinyl alcohol. Alternatively it may be placed in or combined with calcium salts, waxes, paper, hemp, sisal, twine, water soluble materials. It may be in membrane, sponge, sponge type matrix, porous or pumice type structure which may be rigid or flexible, porous or impervious.
In another embodiment of the invention, the particles are impregnated into the paper of the requisite by chemical impregnation using a dry or liquid chemical impregnation either during the manufacturing of the paper or during the manufacture of the requisite. For example, the substances or particles may be incorporated by mixing or blending the particles into a liquid or dry mix, which is then mixed into the pulp from which the paper or the constituents including the filter of the requisite are manufactured. Impregnation may be by soaking the paper or filter in a liquid containing the substances or extracts of the substances. Impregnation may be achieved through bonding the required substance or portions of the substance or ground or desiccated particles of the substance to the paper or filter of the requisite. This method includes bonding by pressure or the use of adhesives or bonding agents. Impregnation can also be achieved by spraying.
In other embodiments, similar methods are used to apply the substance or composition to cigar leaves.
The substance may be rolled into a filter, or form part of the filter paper or be impregnated into the filter paper. In an embodiment of the invention, the substance itself forms a filter or a part of a filter. For example, where the substance is a natural product which occurs in a plant, the filter may be constructed entirely or in part using material from the plant such as its leaf. The leaf may be used in its whole form or shredded and then shaped into a cigarette filter. The construction of the filter may then be similar to that of a conventional cigarette filter. In an embodiment of the invention the filter may be constructed entirely from the plant material or the plant material may be encased in an outer paper sheath in conventional fashion. For example, tea leaves such as green tea leaves may be rolled into a filter or may be used to make a filter.
In an embodiment of the invention, the substance or composition is sandwiched between the filter of a cigarette and the tobacco of the cigarette.
In another embodiment of the invention a carrier which carries the pharmaceutical products, food supplems, natural products or combinations thereof is incorporated or embodied in the smoker's requisite or smoking accessory. The carrier may be in the form of a cartridge, pill, package, membrane or screen which carries the substance and it may be located at any suitable position in the requisite or accessory.
For example, the cartridge or membrane may be located before, after, or in the filter. It may be placed in a smoker's requisite such as a cigarette at either end or at any point along the body of the requisite. The carrier may be refillable or rechargeable for multiple use or disposable.
The act of smoking will then cause at least some of the substance or composition to be carried with the smoke into the mouth, throat and/or lungs of the smoker and thereby cause the substance or composition to be ingested by the smoker.
The invention accordingly extends to a smoker's requisite or accessory which includes a component selected from one or more of tobacco, paper, a filter and a carrier, with a substance as described below embodied in the tobacco, paper, filter or cartridge.
It extends further to a smoker's requisite which includes a filter and in which the filter is formed from a substance as hereinbefore described.
The substance or composition may be selected from flavanols, anelgesics, anti-pyretics, anti-carcinogenic and chemo preventative agents, anti-oxidants, anxiolytics, angiogenisis inhibitors, anti-aging substances, antibiotics, antihistimes and anti-allergenics, anti-hypertensive agents, anti-inflammatories, memory and brain function treatment agents, cardiovascular and circulatory agents, diabetes treatments, anti-hypercholesterolaemics, immune system enhancers, immunizing agents, minerals, respiratory agents, sedatives, anti-stress agents, aphrodisiacs, sexual dysfunction agents, enhancement drugs, tonics, stimulants and vitamins, anti-metabolites, nitrosoureas, tryptamine derivatives, proteins, steroids, vitamins and provitamins, statins, sulphonamides, substituted indoles, substituted imidazoles, metal-containing compounds, drug substances, anti-depressants, immunosuppressants, hormones, antibiotics, phytochemicals, and mixtures of any two or more thereof. Where the substance or composition comprises a mixture e.g. a mixture of natural products, such as a mixture of polyphenols, the substance or composition may comprise a portion or a combination of portions of such mixtures or a combination of such portion or portions with any of the other substances or compositions.
Where a natural substance such as a herb, plant or the like is used, the word “substance” refers to the natural or unrefined substance itself or to a partially or fully refined product produced, distilled, extracted or reduced from the substance.
The alkylating agent may be selected from alkyl sulphonates, ethyleneimine compounds and other alkylating agents. The N-mustard may, for example, be selected from chlorambucil, cyclophosphamide, melphalan, mustine and pipobroman. The alkyl sulphonate may be selected from busulphan and treosulfan. The ethyleneimine compound may be thiotepa. The alkylating agent may instead be selected from hexamethylmelamine, mitobronitol, mutolacetol and ethoglucid.
The substance may be selected from catechin, gallic acid, epigallocatechin gallate, epigallocatechin, epicatechin, epicatechin-3-gallate, epicatechin gallate, epigallocatechin-3-gallate. The tryptamine derivative may be selected from serotonin and melatonin. The protein may be selected from endostatin and angiostatin. The steroid may be selected from steroidal anti-inflammatories. It may for example be an estrogen or estrogen metabolite such as 2-methoxyestradiol.
The substance may be selected from tocopherol, beta-carotene, retinoic acid and ascorbic acid. The statins and compactins may be selected from lovastatin, simvastatin and pravastatin. The sulphonamide may be nimesulide. The substituted indole may be Lodine (etodolac). The metal-containing compound may be a selenium compound.
The natural product may be selected from lycopene, caffeine, prenyl flavonoids, Camelia sinensis and rosemary. The natural product may be of the type found in food and beverages such as the vegetables alfalfa, onions, spinach, broccoli, kale, garlic, red bell peppers and beets, fruits including nanas, red and white grapes, oranges, strawberries, kiwi fruit, grapefruit, pink grapefruit and their seeds, tomato and apple and beverages including teas from Camelia sinensis, apple juice, grape juice, red wine, tomato and orange, and cocoa. It may be plant substance such as Echinacea, ambrosia marijuana/cannabis/hemp or alfalfa. It may be plant material, for example plant material in its natural state from a plant having anti-carcinogenic or other medicinal properties.
The pharmaceutical product may be selected from anti-carcinogenic substances such as traodone, interferon, thalidomide, Col-3, tamoxifen, COX-2 inhibitors, celebrex, rofecoxib (vioxx), imatinib mesylate gleevec (STI 571), cyproheptadine, aspirin and paracetamol. Cyproheptadine is used as an adjunct to radiotherapy and the use of cyproheptadine may be advantageous in radiotherapy. Dosages of 200-300 mg or more of the targeted approach drugs such as C225 which is normally administered intravenously and the molecularly targeted drug such as gleevec result in blood counts in leukemia sufferers returning to normal with minimum side effects.
The anti-depressant may be selected from monoamine oxidase inhibitors such as the hydrazine derivatives, isocarboxazid, phenelzine, nialamide, iproniazid and mebanzine as well as the non-hydrazine monoamine oxidase inhibitors such as pargyline, the tricyclic anti-depressants such as dibenzazepine or zocyclohepetene derivatives such as amitriptyline, butriptyline, desipramine, clomipramine, protriptyline, nortriptyline, opipramol as well as trimipramine and iprindole which have different cyclic structures, and the tetracyclics maprotiline and mianserin.
The flavonoid may be a prenyl flavonoid of the type found in hops and beer i.e. chalcones from hops as well as prenylchalcones and prenylflavonones from naringeninand 2-hydroxy-2-methylbut-3-ene or linalool and xanthohumol from the prenylchalcone in beer.
The food supplement may be a mineral supplement such as a calcium supplement, a vitamin, tonic or stimulant.
The substance or composition may, instead, be a peroxide such as hydrogen peroxide or a synthetic anti-oxidant. The substance or composition may be a natural anti-carcinogen catsclaw, olive leaf (as well as the extract of olive leaf and olive leaf concentrate), pau-d'arco, mistletoe (also sold as iscar and iscador) or cartilage including shark cartilage.
The substance may be selected from the substances and formulations set out in Tables 1 and 2. The amounts of the substance or substances embodied in a smoker's requisite or smoking accessory may be between the lower value as set out in column A of Table 1 and the higher value as set in column C of Table 1 or the amount set out in column C of Table 2. More particularly, the amounts may be as set out in column A of Table 1. Preferred amounts are set out in column B of Table 1 or column D of Table 2. Column C also represents the maximum and minimum daily dose of the relevant substance.
The invention extends to a carrier which is shaped and dimensioned to be received in a smoker's requisite or accessory selected from cigarettes, cigars, cigarette holders, cigar holders and removable filters which incorporates a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, the substance being incorporated in the requisite such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.
The carrier may be a package, cartridge, pill, sponge, matrix, filter, porous membrane, tablet, or string and may have any suitable shape. It may for example be cylindrical, round, rectangular, square, spherical, tubular or coin shaped. It may be manufactured as a polymeric tube and may be porous, impervious, flexible or rigid. It may be a porous or perforated tube which may extend axially down the centre of a cigarette.
The substance may be incorporated into the requisite by manufacturing and configuring it in the form of a string and may be placed or inserted into the requisite or placed on the outside of the requisite. The substance may be impregnated into the string by various methods including use of adhesives, bonding agents, or by soaking, gaseous infusion, immersion, spraying, friction, glueing, impregnation by pressure, sealing, coating or waxing. The string, containing the required substance or plant, may contain binding materials or inert materials to hold or bind the substances together in the form of a string. If the substance to be incorporated is in dry powder, crystalline or granular form the string may be coated with a coating such as wax or fat such as bees wax or cocoa butter to bond the substance or powder. Alternatively, the string may be manufactured partially or wholly from or with the substance to be incorporated into the smoker's requisite.
The carrier provides insulation of the substance and protects it from oxidation, or destruction and to regulate the heat so as to regulate and control release of the substance (i.e. quantity and timing). This string may be stored or coiled into rolls from which lengths as required may be placed into the smoker's requisite at the time of manufacture of the smoker's requisite. Instead, the substance may be impregnated into or embodied in a prior made string. The substance may, instead, be embodied in a band of paper or similar material.
The bands may be applied onto or wrapped around the requisite or may be formed in the paper as an integral part of the paper from which the cigarette is manufactured. The required substance is then carried by the paper and forms an integral part of the cigarette paper. The incorporation or manufacture of the various bands may be done at the time of manufacture of the cigarette paper. These bands may be applied in ring form around the diameter of the smoker's requisite e.g. a cigarette or cigar in lengths which may be straight or otherwise along the length of the cigarette. These bands may also be applied to the cigarette in various patterns including coiled, spiral, in wave form along the length of the cigarette, in zigzag pattern and various other patterns.
The invention extends further to a smoking accessory selected from cigarette holders, cigar holders and detachable filters which incorporates a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof.
It extends further to a method of making a smoker's requisite which embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, which includes combining a component of a smoker's requisite with the substance and using the component to make the requisite.
The invention extends, further, to a method of administering to a person a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof which includes the step of incorporating the substance in a smoker's requisite as hereinbefore described so that, when the smoker's requisite is smoked by a person, an amount of the substance or composition is ingested by the person during smoking.
The invention extends further to a method of administering to a person a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof which includes the step of incorporating the substance in a smoking accessory as hereinbefore described so that, when the smoking accessory is used together with a smoker's requisite, an amount of the substance is ingested by the person during smoking.
According to another aspect of the invention, there is provided a method of making a smoker's requisite which embodies a substance selected from pharmaceutical products, food supplements, natural products and combinations thereof, which includes incorporating a carrier which carries the substance in the smoker's requisite so that when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.
The substance may be a combination of one or more of the pharmaceutical products, food supplements and natural products.
In preferred embodiments of the invention the substance or composition comprises, in combination, novastatin and Lodine or in combination a statin such as mevacor (lovastatin) and a COX-2 inhibitor such as celebrex, vioxx or nimesulide or in combination mevacor (lovastatin) and Lodine XL. In another preferred embodiment of the invention the substance or composition comprises mycopene, a selenium compound and green tea. In another preferred embodiment the substance or composition comprises epigallocatechin-3-gallate, epigallocatechin, epicatechin gallate and/or epicatechin-3-gallate. In another preferred embodiment the substance or composition is a combination of epigallocatechin gallate and curcumin. A combination of catechins is better than epigallocatechin alone for producing cell apoptosis. The effect is synergistically increased when catechins are combined with other anti-carcinogenic substances such as tamoxifen. In another preferred embodiment a seratonin antagonist such as periactin (cyproheptadine) can be used alone or in conjunction with melatonin. A dosage of 36 mg of melatonin daily as an adjuvant in conjunction with traditional cancer treatments reduces the side effects of toxic therapies and increases their effectiveness.
An anti-carcinogenic substance, for the purposes of this specification, is a substance which acts against cancer in a prophylactic fashion or is a substance which can be used in the treatment of cancer, for example in a chemotherapeutic fashion.
The smoking of a smoker's requisite or the use of a smoking accessory as hereinbefore described incorporating extracts of Camelia sinensis results in the ingestion of epigallocatechin gallate. This compound has been shown to be active amongst others against colon cancer, melanoma, breast cancer and lung cancer.
In order to inhale and ingest the various compounds and substances of the invention, certain of these have to be broken down, diffused or vapourised so that they can be transported into the draft or flow of air and smoke being drawn in by the smoker or diffused and released into the atmosphere where it could be breathed by a passive smoker.
Heat generated by the glowing end of a cigarette, will gradually permeate along the length of the cigarette. The resulting increase in temperature, depending upon the substance or composition used, will allow or cause the substance or composition to be progressively released and inhaled by the smoker. Different substances will be released at different temperatures. The end of a cigarette which is closest to the user when being smoked will initially be cooler than the opposite end and will gradually increase in temperature as the cigarette is smoked. The release of the substances is optimised by the positioning of the substances in the requisite. With certain substances that are more sensitive to heat or require only a small amount of heat to release them or their required active ingredient, the substance is placed at the end of the requisite closest to the smoker's mouth. At this end, the substance is not immediately subjected to the extreme heat generated at the lit end. This preserves the integrity of the substance for a longer period. The substance is then subjected to a gradual increase in temperature as the lit end approaches the area where the substance has been placed. The rise in temperature and/or the air drawn through the cigarette causes the active ingredients to be released. The constituents so released are then be ingested by the person smoking the requisite.
The substance or composition may be placed along the length of the cigarette or at any point where it will reach the optimal temperature for the optimal period of time. This would be predetermined before manufacture by taking into account which substance is to be used and may be determined by routine experimentation.
The cigarette or cigar holder may be openable by a flip, screw, bayonet taper or push-in mechanism and an anti-carcinogenic package, food supplement package, medication package or anti-depressant package, filter or membrane may be receivable in the accessory. The holder may be attachable to a cigarette or cigar by a push, taper or friction fit.
The invention extends to an anti-carcinogenic cartridge which can be inserted into a cigarette holder, cigar holder or pipe.
For purposes of this specification the words “substance” and “material” include any compound, mixture, blend, medication, formula, drug (synthetic or natural), hormone, plant, seed, pollen, flower, vegetable, fruit or bio-organism and includes the above in their natural, organic or synthetic form or a derivative or modification of any of them and when used in their whole, part, refined or unrefined form or only a portion or any constituent of, extract, fraction, molecule or distillate derived from any of the above or a portion of the aforegoing (extract) in its refined or unrefined form or a synthetically manufactured derivative or substitute of any of the aforegoing. Any of these may be used individually or in combination with each other or with other remedies, formulae or substances.
The mass and bulk of some of the formulae of this invention require that the formulation be carried in a cartridge which is inserted into a filter which is detachable from the cigarette. The detachable filter may be pre-packed with a substance of medication and may be in the form of a disposable single use filter or it may be used until the medication or substance is depleted. Alternatively the filter may be in a form where it may be re-used in which instance a fresh cartridge/carrier is inserted.
The filter is pushed onto the end of the requisite which may be filterless or already have a filter and may be held in place by a ringed sleeve which can be rigid or flexible.
The medication may then be incorporated into the filter by one of the methods described above or by the insertion of the “carrier”.
The medication can also be incorporated by the insertion of a porous membrane which carriers the medication.
A non-porous membrane may be used behind which the medication is packed or stored. The medication may be sandwiched between two membranes or between a membrane and the tobacco portion of the requisite. Alternatively the medication may be carried or housed in a cartridge through which the smoke from the burning tobacco can pass. The cartridge may have a porous or non-porous membrane on one or both sides through which the smoke can pass.
The cartridge or carrier may be made from porous paper, material, or cellulose. When the detachable filter is forced onto the end of the requisite the membrane is pierced and the medication is exposed to the draught/flow of air which passes from the lit end of the requisite to the smokers mouth. The non-porous membrane may also be impregnated with a medication.
The cartridge or insert which is incorporated in the smoker's requisite or accessory protects the integrity of the active ingredients incorporated into the requisite or accessory both during the time the requisite is in storage and during the time it is being consumed and can reduce the temperature to which the substance is exposed during the smoking of the requisite and further allow for the pre-positioning of the substance within the requisite so that the timing of the release and the amount of the substance may be predetermined and controlled. The use of a cartridge or insert to incorporate any particular substance in a smoker's requisite allows easier incorporation of the substance during the manufacturing process. The use of a cartridge or insert allows easier substitution of alternate substances or medications to be incorporated into a requisite without major changes to the manufacturing process when a change of the substance is required.
To regulate the amount of active ingredient or substance released during the smoking of the requisite, the cartridge or insert may be rigid or flexible and may be porous. The degree of porosity may also be varied to determine the amount of air or smoke which passes through it. The draught of air or smoke passing through the insert or cartridge assisted by the heat, releases the active ingredient of the substance in the cartridge.
In addition to air or smoke passing through a selected substance or cartridge or insert, the active ingredients may be dispensed or released by air, smoke or heat passing over or around the substance, the cartridge or insert.
Alternatively the active ingredients can be released or diffused at the time that the cartridge or insert heats up or is burnt. When using this method the cartridge or insert may be of a non-porous or semi-porous nature.
More than one cartridge may be incorporated into a smoker's requisite. The content, make up and construction of the various cartridges may differ from each other and more than one type of cartridge or insert may be incorporated into a smoker's requisite.
The insert or cartridge carriers the substance and dispenses or infuses the substance into the requisite either before or during the igniting and combustion of the smoker's requisite. Such infusion or dispensing into the requisite can be achieved by way of diffusion. The cartridge or insert may also be manufactured from a porous material or a porous membrane so that the substance can diffuse through the walls of the cartridge or insert. Alternatively dispensing or diffusion can be achieved by holes or perforations in the cartridge or insert.
The dosage or amount of substance delivered to the smoker can be varied by increasing or decreasing the quantity and size of cartridges incorporated into the requisite or increasing or decreasing the amount of string incorporated into the requisite or by varying the porosity of the insert or cartridge or by increasing the number or size or perforations in the insert or cartridge.
Instead the substance may be placed at any point in the requisite. The substance may be housed in a cavity or pocket anywhere in the requisite or in a cavity or pocket sandwiched between the filter and the section of the requisite containing the tobacco or within a cavity or pocket either in the tobacco portion or filter portion of the requisite or combined in the paper or glue.
In another embodiment of the invention, the substance in a desiccated, shredded or ground state may be blended into an inert carrier, which is then placed into the requisite or filter. The inert carrier, which encases the substance is selected so as to release the substance or the active material from the substance at a predetermined temperature and to protect the integrity of the substance from excessive heat until it can be ingested or inhaled by the smoker.
Another method of incorporation is to fold or roll the particles into the filter at the time of manufacture of the filter.
Another method of incorporation is to blend or mix the particles into the tobacco mix.
In yet another embodiment, the substance is incorporated into the filter of the requisite. The substance may be incorporated by rolling, folding or impregnating it into the filter or filter paper.
In yet another embodiment the Camellia sinensis or rosemary plant or certain of the constituents of the Camellia sinensis or rosemary plant or a combination of the plants may be incorporated into the body of the requisite where the tobacco is housed or used as described above.
In yet another embodiment, the process and method used in the manufacture of a conventional cigarette filter is employed using material selected from a plant.
In yet another embodiment the plant material may be incorporated into a filter made from the materials and according to the process employed in the manufacture of a conventional cigarette filter.
In yet another embodiment portions of the plant material are placed in a porous cartridge which is then incorporated into the smoker's requisite.
Naturally, more than one of the substances can be used in a single smoker's requisite or accessory.
The invention is now described, by way of example, with reference to the following Examples.

EXAMPLE 1

Mevacor (lovastatin) and Lodine XL were combined with cigarette tobacco and formed into a cigarette. The amount of Mevacor (lovastatin) incorporated was 50 mg and the amount of Iodine XL was 4 mg. The preferred daily dosage of lovastatin is 1000 mg and that of Lodine XL 80 mg per day.

EXAMPLE 2

Cyproheptadine was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of cyproheptadine incorporated was 0.2 mg. The preferred daily dosage of Cyproheptadine is 4 mg. The daily intake of Cyproheptadine may vary between 4-12 mg.

EXAMPLE 3

Melatonin was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of melatonin incorporated was 1.8 mg. The preferred daily dosage of melatonin is 36 mg. The daily intake of melatonin may vary between 3-200 mg.

EXAMPLE 4

Tamoxifen was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of tamoxifen incorporated was 1 mg. The preferred daily dosage of tamoxifen is 20 mg. The daily intake of tamoxifen may vary between 10-40 mg.

EXAMPLE 5

A formulation consisting of 1.8 mg of Melatonin and 0.2 mg Cyproheptadine was mixed with cigarette tobacco and the tobacco was formed into a cigarette.

EXAMPLE 6

Cyproheptadine was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of cyproheptadine was selected so that, by smoking a predetermined number of cigarettes per day, a dose of 4 mg of the cyproheptadine was delivered to a smoker.

EXAMPLE 7

Flavonols were mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of flavonols incorporated was 25 mg. The preferred daily dosage of flavonols is 20 mg. The daily intake of flavonols may vary between 10-1000 mg.

EXAMPLE 8

Endostatin was mixed with cigarette tobacco and the tobacco was formed into a cigarette. The amount of endostatin incorporated was 15 mg. The preferred daily dosage of endostatin is 300 mg. The daily intake of indostatin may vary between 3.75-600 mg.

EXAMPLE 9

Melatonin and Cyproheptadine were combined with cigarette tobacco and formed into a cigarette. The amount of Melatonin incorporated was 1.8 mg and the amount of Cyproheptadine was 0.2 mg. The preferred daily dosage of malatonin is 36 mg and that of Cyproheptadine is 4 mg per day. The daily intake of Melatonin may vary between 3-200 mg per day and that of Cyproheptadine 4-12 mg per day.

EXAMPLE 10

The procedure of Examples 1 and 2 was followed but the active ingredients were impregnated into the paper of the cigarette.

EXAMPLE 11

Plant material extracted from the Camellia sinensis and rosemary plant were cut, blended and rolled into the form of a string. An inert tasteless binding agent was used to hold the string together. This string was coiled onto a core or spindle for storage and ease of handling. From this coil a length was cut and inserted into a cigarette at the time of manufacture. In use, when the cigarette was smoked, the string burned gradually down the length of the cigarette. The plant material gradually released its active ingredients as the string burned. The string was subjected to an increasing temperature from ambient gradually rising along the length of the string as the burning end of the cigarette proceeded down the length of the cigarette. The progressive increase in temperature allowed the string to release its active components. The components were ingested by the smoker by inhalation.

EXAMPLE 12

Example 11 was repeated but instead of arranging the string linearly along the length of the cigarette it was coiled cylindrically along the cigarette close to the outer paper. In this embodiment the dosage and delivery of the active ingredient was increased as more string containing the active ingredient was incorporated into the cigarette than was incorporated in Example 4.

EXAMPLE 13

Example 11 was repeated but the string was coiled in a smaller diameter coil down the approximate centre line of the cigarette along its length.

EXAMPLE 14

Example 11 was repeated and in this case a tightly compressed coil of string configured in the shape of a watch spring but more tightly wound was incorporated and sandwiched between the filter and tobacco of the requisite.

EXAMPLE 15

Example 11 was repeated several more times and active ingredient in each example was varied by altering the configuration in which the string was incorporated into the requisite. When the string was tightly coiled with the coils being closely spaced to each other, the amount of string in relation to the length of the requisite was increased resulting in a higher concentration of active ingredient per length of requisite. The dosage and delivery rate was altered by either using a loosely wound spaced coil, which resulted in a lower concentration of active ingredient per length of requisite or a tightly wound spaced coil which provided a higher concentration and consequently a higher dosage. To obtain variation in the amount of active ingredient delivered the string was incorporated into the cigarette in various configurations including coiling, zigzagging, straight lengths, wave pattern, rings, individual rings, linked rings, joined looped rings, U-shape, linked U-shape patterns as well as watch spring and Catherine Wheel type patterns.
In one embodiment, the string coil was wound on the outside of the cigarette along its length. In another embodiment, a tightly compressed coil was placed in the filter section of the cigarette. In another embodiment, more than one coil was used and interspersed through the filter of the cigarette. In another embodiment, the coil was placed in the tobacco section of the cigarette.
In another embodiment, more than one coil was used and these were placed in the filter section as well as the tobacco section of the cigarette. In another embodiment, more than one coil was used and these were placed in the filter section as well as the tobacco section of the cigarette.

EXAMPLE 16

1000 mg of the analgesic Paracetamol in powder form was encased in a porous cylindrical hollow barrel type cartridge which was then placed longitudinally into a cigarette.

EXAMPLE 17

A porous cartridge was manufactured in which a mix of Epigallocatechin gallate (25 mg) and curcumim (37.5 mg) were placed. This was incorporated in a cigarette directly in front of the filter so that it was sandwiched between the filter and the tobacco of the cigarette.

EXAMPLE 18

Example 10 was repeated and the cartridge was placed in the filter portion of the cigarette.

EXAMPLE 19

A filter for a cigarette was manufactured in which a mixture of Epigallocatechin gallate (25 mg) and curcumin (37.5 mg) from turmeric was impregnated into the filter material. This filter was then used in the manufacture of a smoker's cigarette.

EXAMPLE 20

A filter for a cigarette was manufactured using parts of the Camellia sinensis plant and incorporating these into the filter by rolling and folding strips and portions of the plant into the filter paper.

EXAMPLE 21

Example 20 was repeated four more times with the following changes.
In one embodiment, the plant material was ground and lodged in the filter during the manufacture of the filter.
In another embodiment, the constituent parts of the Camellia sinensis plant were bonded to the filter paper prior to the manufacture of the filter.
In another embodiment, the constituent parts were made to adhere to the filter paper by using pressure to impress these into the paper.
In another embodiment, the constituents of the Camellia sinensis plant were bonded to the filter paper using bonding material which would not adversely affect the taste of the cigarette when this was smoked.

EXAMPLE 22

A filter was constructed using large unrefined sections of the Camellia sinensis plant which were processed and rolled to form a filter.

EXAMPLE 23

Example 22 was repeated but the Camellia sinensis plant was shredded into smaller sections, before being rolled into the shape of a filter.

EXAMPLE 24

Example 22 was repeated using shredded sections of the Camellia sinensis plant.

EXAMPLE 25

A cigarette was made using a blend of shredded Camellia sinensis plant and tobacco.

EXAMPLE 26

Plant material selected from the plant materials of the invention were finely ground and then compacted and tightly packed in a porous cartridge which was then incorporated into a cigarette directly in front of the filter. This cartridge was held in place by being sandwiched between the filter and the tobacco of the requisite.

EXAMPLE 27

Example 26 was repeated several times but the cartridges were placed at various points within the length of the tobacco portion of the cigarette.

EXAMPLE 28

Example 26 was repeated but the cartridge was placed in the filter.

EXAMPLE 29

Example 26 was repeated but more than one cartridge was placed in the tobacco section and in the filter of the cigarette.

EXAMPLE 30

Pulp from grapefruit was desiccated and ground to around 60/100 mesh. Seeds from the grapefruit were dried and ground to around 60/100 mesh. The pulp and seed particles were blended and 50 ml of this blend was mixed into a tobacco mix from which a cigarette was manufactured. This provides protection for humans against mosquito and mosquito related diseases such as malaria.

EXAMPLE 31

In further embodiments, the blend was impregnated into the filter or the cigarette paper or incorporated into a string and used as in Examples 4-8 or incorporated into a porous cartridge and used as in Examples 20-23.

EXAMPLE 32

Pulp from grapefruit was desiccated and ground to around 60/100 mesh. Seeds from the grapefruit were dried and ground to around 60/100 mesh. The pulp and seed particles were blended and 50 mg of this blend was added to 55 mg of artemisia annua and 10 mg of berberine. This mix was mixed into tobacco from which a cigarette was manufactured.

EXAMPLE 33

Examples 11-29 were repeated using the blend of Example 32.
It is an advantage of the invention illustrated that, in the case of a person who is smoking or addicted to smoking, the incorporation of an anti-carcinogenic compound in a cigarette, or in pipe tobacco or the like should serve to reduce or possibly prevent the incidence of cancer which can be caused through smoking. It is also an advantage of the invention illustrated that, where a person has contracted, for example, lung cancer through smoking but nevertheless refuses to stop smoking, the method of the invention can be used to dose the person with a chemotherapeutic agent to treat the cancer. It is also an advantage of the invention illustrated that the invention may be used to provide nutrition, food supplements, drugs, vitamins, remedies or medications to a smoker who may not have cancer.

FORMULA	Methylsulphonylmethane (MSM)							500	mg
	Pycnogenol							60	mg
	Epigallocatechin gallate (EGCg)							500	mg
	D-alpha tocopheryl succinate							100	mg
		0.058-87	mg	58	mg	116-1740	mg	1160	mg
FORMULA	Selenium							100	mcg
	Pine bark extract							100	mg
	Grapeseed extract							100	mg
	Epigallocatechin gallate (EGCg)							500	mg
	D-alpha tocopheryl succinate							100	mg
		4-60	mg	40.0	mg	80-1200.15	mg	800.1	mg
FORMULA	Beta carotene							15	mg
	Cryptoxanthin							0.025	mg
	Alpha carotene							0.1	mg
	Zeaxanthin							0.02	mg
	Lutein							10	mg
	Lycopene							10	mg
	Epigallocatechin gallate (EGCg)							500	mg
	Vaccinium myrtillus							60	mg
		2.98-44.64	mg	29.7	mg	59.51-892.71	mg	595.14	mg
	Gamma-Aminobutyric Acid	50-200	mg	75	mg	1-4	g	1.5	g
	Piper methysticum	5-35	mg	15	mg	100-700	mg	300	mg
	Standardized Extract (30%-70%
	kavalactones)
	Scutellaria lateriflora	50-150	mg	50	mg	1-3	g	1	g
FORMULA	Piper methysticum							300	mg
	Standardized Extract (30%-70%
	kavalactones)
	Gamma-Aminobutyric Acid							1.5	mg
	Eleutherococcus senticosus							1000	mg
		6.51-97.61	mg	65.08	mg	130.1-1952.25	mg	1301.5	mg
Formula	Crataegus oxycanthus							1500	mg
	Coenzyme Q10							50	mg
	Leonurus cardiaca							500	mg
	Lycopus virginicus							100	mg
	epigallocatechin gallate (EGCg)							500	mg
		26.5-172.5	mg	132.5	mg	530-3450	mg	2650	mg
	Hypericum perfoliatum	15-45	mg	45	mg	300-900	mg	900	mg
	(as standarized extract of 0.3%
	Hypericin)
	5-Hydroxy-tryptophan	15-30	mg	5	mg	300-600	mg	100	mg
	(as seed extract of Griffonia
	simplificolia)
	Lavandula officinalis	0.1-0.2	ml	0.15	ml	2-4	ml	3	ml
	Sterculia acuminata	0.1-0.6	ml	0.15	ml	2-12	ml	3	ml
	Panax Ginseng	25-150	mg	50	mg	0.5-3	g	1000	mg
	Eleutherococcus senticosus	10-150	mg	50	mg	200-3000	mg	1000	mg
	Panax quinquefolius	25-150	mg	50	mg	0.5-3	g	1000	mg
	Strychnos ignatii	0.03-0.15	ml	0.05	ml	0.6-3	ml	1	ml
	Turnera diffusa	0.1-0.2	ml	0.15	ml	2-4	ml	3	ml
	Rhodiola rosea	0.025-0.15	ml	0.075	ml	0.5-3	ml	1.5	ml
	Urtica urens	0.1-0.6	ml	0.25	ml	2-12	ml	5	ml
	Euphrasia officinalis	0.1-0.6	ml	0.25	ml	2-12	ml	5	ml
	Ephedra (Ma Huang 1:4 Ø)	0.125-0.375	ml	0.25	ml	2.5-7.5	ml	5	ml
Formula	Ephedra (Ma Huang 1:4 Ø)							500	mg
	Euphrasia officinalis							500	mg
	Ascorbic acid							500	mg
		7.55-112.5	mg	75	mg	150-2250	mg	1500	mg
Formula	Achillea millefolium							5	ml
	Viscum album							1	ml
	Taraxacum officinale							4	ml
	Tilia platyphyllos							4	ml
	Allium sativum							1	ml
		0.075-1.125	ml	0.75	ml	1.5-22.5	ml	15	ml
Formula	Achillea millefolium							5	ml
	Viscum album							1	ml
	Taraxacum officinale							4	ml
	Tilia platyphyllos							4	ml
	Valeriana officinalis							5	ml
	Scutellaria lateriflora							4	ml
		0.115-1.725	ml	1.15	ml	2.3-34.5	ml	23	ml
	Glucosamine sulphate	12.5-75	mg	75	mg	250-1500	mg	1500	mg
	Chondroitin sulphate	5-25	mg	25	mg	100-500	mg	500	mg
	Curcumin	12.5-50	mg	12.5	mg	250-1000	mg	250	mg
	Salix alba	50-100	mg	12.5	mg	1000-2000	mg	250	mg
	Tanacetum parnethium	12.5-75	mg	12.5	mg	250-1500	mg	250	mg
	Methylsulphonylmethane (MSM)	5-50	mg	25	mg	100-1000	mg	500	mg
	Boswellia serrata	0.5-25	mg	12.5	mg	10-500	mg	250	mg
Formula	Glucosamine sulphate							1500	mg
	Chondroitin sulphate							500	mg
	Curcumin							250	mg
	Salix alba							250	mg
	Tanacetum parnethium							250	mg
	Methylsulphonylmethane (MSM)							500	mg
	Equisetum arvensis							50	mg
	Copper lysinate							1	mg
	Zinc glycinate							10	mg
	Manganese sulphate							2	mg
	Chelated Selenium							0.1	mg
	Epigallocatechin gallate (EGCg)							500	mg
		19.07-285.98	mg	190.66	mg	381.3-5719.65	mg	3813.1	mg
Formula	Glucosamine sulphate							1500	mg
	Chondroitin sulphate							500	mg
	Curcumin							250	mg
	Boswellia serrata							250	mg
	Epigallocatechin gallate (EGCg)							500	mg
	Methylsulphonylmethane (MSM)							500	mg
	Epigallocatechin (EGC)							200	mg
	Pycnogenol							60	mg
		18.8-282	mg	188	mg	376-5640	mg	3760	mg
	Epigallocatechin gallate (EGCg)	5-125	mg	25	mg	100-2500	mg	500	mg
	Epicatechin gallate (ECG)	75-750	mg	150	mg	1.5 g-15	g	3	g
	Epigallocatechin (EGC)	75-750	mg	150	mg	1.5 g-15	g	3	g
	Gallocatechin gallate (GCG)	75-750	mg	150	mg	1.5 g-15	g	3	g
	Gallocatechin (GC)	75-750	mg	150	mg	1.5 g-15	g	3	g
	Epicatechin (EC)	75-750	mg	150	mg	1.5 g-15	g	3	g
	Catechin (C)	75-750	mg	150	mg	1.5 g-15	g	3	g
	Epigallocatechin-3-gallate	5-125	mg	25	mg	100-2500	mg	500	mg
	Epicatechin-3-gallate	75-750	mg	150	mg	1.5 g-15	g	3	g
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Epicatechin (EC)							3000	mg
	Epicatechin gallate (ECG)							3000	mg
	Epigallocatechin (EGC)							3000	mg
	d-alpha tocopheryl acetate							100	mg
	Ascorbic acid							250	mg
		49.25-738.75	mg	492.5	mg	985-14775	mg	9850	mg
	Gingko biloba	0.5-12	mg	6	mg	10-240	mg	120	mg
	(Standard extract)
	Hydrocotyle asiatica	5-30	mg	15	mg	100-600	mg	300	mg
	Dimethylaminoethanol Bitartrate	5-20	mg	10	mg	100-400	mg	200	mg
	(DMAE)
	Rivastigamine	0.075-0.3	mg	0.3	mg	1.5-6	mg	6	mg
Formula	Gingko biloba							120	mg
	(Standard extract)
	Hydrocotyle asiatica							300	mg
	Dimethylaminoethanol Bitartrate							200	mg
	(DMAE)
	Chromium GTF							100	mcg
	Thiamine hydrochloride							20	mg
	Riboflavin							20	mg
	Nicotinamide or Niacinamide							20	mg
	Calcium d-Pantothenate							20	mg
	Phosphatidyl Choline							50	mg
		3.76-56.26	mg	37.5	mg	75.1-1125.15	mg	750.1	mg
	Trigonella foenum-graecum	5-100	mg	10	mg	0.1 g-2	g	200	mg
	Oplopanax horridum	0.1-0.6	ml	0.2	ml	2-12	ml	4	ml
	Phaseolus vulgaris	0.1-0.6	ml	0.2	ml	2-12	ml	4	ml
	Vaccinium myrtillus	0.1-0.6	ml	0.2	ml	2-12	ml	6	ml
Formula	Trigonella foenum-graecum							3	ml
	Oplopanax horridum							4	ml
	Phaseolus vulgaris							4	ml
	Vaccinium myrtillus							6	ml
		0.085-1.275	ml	0.85	ml	1.7-25.5	ml	17	ml
	Echinacea purpurea	2.5-150	mg	150	mg	50-3000	mg	3000	mg
	Olea europea extract	25-50	mg	50	mg	500-1000	mg	1000	mg
	Containing 12% Oleuropein
	Astragalus mebricanaceus root	12.5-1500	mg	75	mg	0.25-30	g	1.5	g
	Hydrastis canadensis root	12.5-150	mg	150	mg	250-3000	mg	3000	mg
	Allium sativa	12.5-1500	mg	250	mg	0.25-30	g	5	g
	Calendula officianalis	50-100	mg	75	mg	1-2	g	1.5	g
Formula	Echinacea purpurea							3000	mg
	Hydrastis canadensis root							3000	mg
	Astragalus mebricanaceus root							1500	mg
		0.038-0.56	g	0.38	g	0.75-11.25	g	7.5	mg
Formula	Sambucus canadensis							2	g
	Echinacea purpurea							3000	mg
	Hydrastis canadensis root							3000	mg
	Allium sativa							5	g
		0.065-0.975	g	0.65	g	1.3-19.5	g	13	g
Formula	Artemesia annua							750	mg
	Berberine							150	mg
	Grapefruit seed extract							750	mg
	Allium sativa							2500	mg
		20.75-311.25	mg	207.5	mg	415-6225	mg	4150	mg
	Sambucus nigra	0.1-0.6	ml	0.3	ml	2-12	ml	6	ml
	Achillea millefolium	0.1-0.6	ml	0.3	ml	2-12	ml	6	ml
	Mentha piperita	0.1-0.6	g	0.25	g	2-12	g	5	g
Formula	Triprolidine HCl							3.75	mg
	Pseudoephedrine HCl							90	mg
	Ascorbic acid							1500	mg
	Echinacea purpurea							1.5	g
		7.98-119.64	mg	79.76	mg	159.53-2392.88	mg	1595.25	mg
Formula	Lecithin					10-5000	mg	500	mg
	Nicotinic acid					1-1500	mg	100	mg
	Chromium polynicotinate					0.01-0.3	mg	0.2	mg
	Allium sativa					10-5000	mg	500	mg
	Dioscorea villosa					100-3000	mg	1000	mg
	DHEA					10-150	mg	50	mg
		21.5-140	mg	107.51	mg	430-2800	mg	2150.2	mg
	Althea officinalis	0.1-0.75	ml	0.25	ml	2-15	ml	5	ml
	Angelica archangelica	0.1-0.6	ml	0.2	ml	2-12	ml	4	ml
	Cephaelis ipecacuanha	0.0125-0.15	ml	0.05	ml	0.25-3	ml	1	ml
	Plantago lanceolata	0.1-0.6	ml	0.25	ml	2-12	ml	5	ml
	Thymus vulgaris	0.1-0.6	ml	0.2	ml	2-12	ml	4	ml
	Salvia officinalis	0.05-0.6	ml	0.2	ml	1-12	ml	4	ml
	Commiphora myrrha	0.1-0.75	ml	0.25	ml	2-15	ml	5	ml
	Drosera spp.	0.025-0.15	ml	0.05	ml	0.5-3	ml	1	ml
Formula	Althea officinalis							5	ml
	Thymus vulgaris							4	ml
	Salvia officinalis							4	ml
		0.065-0.975	ml	0.65	ml	1.3-19.5	ml	13	ml
Formula	Plantago lanceolata							5	ml
	Commiphora myrrha							5	ml
	Drosera spp.							1	ml
	Ephedra (Ma Huang 1:4 Ø)							3	ml
		0.07-1.05	ml	0.7	ml	1.4-21	ml	14	ml
	Humulus lupulus	25-150	mg	100	mg	500-3000	mg	2000	mg
	Piper methysticum	5-35	mg	15	mg	100-700	mg	300	mg
	Standardized Extract (30%-70%
	kavalactones)
	Passiflora incarnata	0.025-0.15	ml	0.1	ml	0.5-3	ml	2	ml

Valeriana species

0.1-0.5

ml

0.25

ml

2-10 ml/2 hours

5

ml

	Avena sativa	0.05-0.25	ml	0.15	ml	1-5	ml	3	ml
Formula	Humulus lupulus							250	mg
	Piper methysticum							350	mg
	Passiflora incarnata							250	mg
	Valeriana species							500	mg
	Avena sativa							500	mg
	Melatonin							3	mg
		9.27-138.98	mg	92.65	mg	185.3-2779.5	mg	1853	mg
Formula	Piper methysticum							300	mg
	Standardized Extract (30%-70%
	kavalactones)
	Valerian							1000	mg
	gamma-Aminobutyric Acid							1500	mg
		14-210	mg	140	mg	280-4200	mg	2800	mg
	Turnera diffusa	0.1-0.6	ml	0.2	ml	2-12	ml	4	ml
	Serenoa serrulata	0.025-0.15	g	0.075	g	0.5-3	g	1.5	g
Formula	Turnera diffusa							4	ml
	Serenoa serrulata							5	ml
	Avena sativa							3	ml
		0.06-0.9	ml	0.6	ml	1.2-18	ml	12	ml
	Panax Ginseng	0.5-150	mg	37.5	mg	10-3000	mg	750	mg
	Panax Quinefollium	0.5-100	mg	25	mg	10-2000	mg	500	mg
	Eleutherococcus senticosus	0.5-200	mg	50	mg	10-4000	mg	1000	mg
	Centella asiatica	0.5-50	mg	30	mg	10-1000	mg	600	mg
	Paullina guarana	2.5-10	mg	10	mg	50-200	mg	200	mg
	Schisandra chinesis	0.5-50	mg	25	mg	10-1000	mg	500	mg
	Pfaffia paniculata	0.025-0.225	g	0.15	g	0.5-4.5	g	3	g
Formula	Panax Ginseng							750	mg
	Centella asiatica							500	mg
	Paullina guarana							100	mg
	Schisandra chinesis							250	mg
	Pfaffia paniculata							500	mg
	Epigallocatechin gallate (EGCg)							500	mg
		11.75-176.25	mg	117.5	mg	235-3525	mg	2350	mg
	Thiamine hydrochloride	0.05-5	mg	5	mg	1-100	mg	100	mg
	Riboflavin	0.05-5	mg	5	mg	1-100	mg	100	mg
	Nicotinamide or Niacinamide	0.05-5	mg	5	mg	1-100	mg	100	mg
	Nicotinic acid or Niacin	0.05-5	mg	5	mg	1-100	mg	100	mg
	Pantothenic acid	0.05-5	mg	5	mg	1-100	mg	100	mg
	Calcium d-Pantothenate	0.05-5	mg	5	mg	1-100	mg	100	mg
	Pyridoxine hydrochloride	0.05-5	mg	5	mg	1-100	mg	100	mg
	Cyanocobalamin	0.75-50	mcg	5	mcg	15-1000	mcg	100	mcg
	Pangamic acid	0.05-25	mg	15	mg	1-500	mg	300	mg
	Biotin	0.05-15	mcg	15	mcg	1-300	mcg	300	mcg
	Choline	0.25-25	mg	12.5	mg	5-500	mg	250	mg
	Inositol	0.05-750	mg	12.5	mg	1-1500	mg	250	mg
	Para-amino benzoic acid	0.05-50	mg	5	mg	1-1000	mg	100	mg
	Phosphatidyl Choline	5-200	mg	50	mg	100-4000	mg	1000	mg
	Lecithin	5-200	mg	50	mg	100-4000	mg	1000	mg
Formula	Retinol palmitate							1.5	mg
	Thiamine hydrochloride							10	mg
	Riboflavin							5	mg
	Nicotinamide or Niacinamide							50	mg
	Pantothenic acid							15	mg
	Calcium d-Pantothenate							15	mg
	Pyridoxine hydrochloride							10	mg
	Cyanocobalamin							50	mcg
	Folic acid or Folacin							400	mcg
	Biotin							100	mcg
	Choline							250	mg
	Inositol							250	mg
	Para-amino benzoic acid							100	mg
	Ascorbic acid							1000	mg
	Cholecalciferol							5	mcg
	d-alpha Tocopheryl acetate							2.5	mcg
		8.54-128.03		85.35	mg	170.70-2560.59	mg	1707.06	mg
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Endostatin							300	mg
	epicatechin gallate (ECG)							2700	mg
		35-227.5	mg	175	mg	700-4550	mg	3500	mg
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Lovastatin							80	mg
	epicatechin gallate (ECG)							2700	mg
		32.5-213	mg	164	mg	650-4260	mg	3280	mg
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Lodine XL							1000	mg
	epicatechin gallate (ECG)							2700	mg
		42-273	mg	210	mg	840-5460	mg	4200	mg
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Curcumin							750	mg
	epicatechin gallate (ECG)							3000	mg
		42.5-275	mg	212.5	mg	850-5500	mg	4250	mg
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Tamoxifen							20	mg
	epicatechin gallate (ECG)							3000	mg
		42.5-275	mg	212.5	mg	850-5500	mg	4250	mg
Formula	Epigallocatechin gallate (EGCg)							500	mg
	Selenium							0.2	mg
	Lycopene							10	mg
	epicatechin gallate (ECG)							3000	mg
		35-228	mg	175.51	mg	700-4560	mg	3510.2	mg

TABLE 2

UNIT DOSAGE

Name/Substance/
Compound/Active Ingredient	A	B	C	D	E

	Acetylsalycilic acid	0.3-4	g	250	mg
	Paracetamol	0.5-4	g	0.5	g
	Ibuprofen	0.6-1.2	g	200	mg
	Indomethacin	50-150	mg	25	mg
	Mefenamic acid	500-1500	mg	250	mg
	Naproxen	250-750	mg	250	mg
	Codeine Phosphate	10-60	mg	5	mg
	dl-Phenylalanine	500-1500	mg	500	mg
	Salix alba	1000-2000	mg	250	mg
	Tanacetum parnethium	250-1500	mg	250	mg
	Paracetamol	2000	mg	500	mg
	Codeine Phosphate	20	mg	5	mg
	Clomipramine HCl	10-75	mg	25	mg
	Nortriptyline HCl	25-100	mg	25	mg
	Imipramine HCl	75-150	mg	25	mg
	Dothepin HCl	25-75	mg	25	mg
	Trimipramine HCl	50-100	mg	50	mg
	Mianserin HCl	30-90	mg	10	mg
	Fluoxetine HCl	20-80	mg	20	mg
	Paroxetine HCl	10-50	mg	10	mg
	Citalopram hydrobromide	20	mg	20	mg
	Sertraline HCl	50-200	mg	50	mg
	Verilafaxine HCl	37.5-75	mg	37.5	mg
Formula	Hypericum perfoliatum	50-900	mg	300	mg
	(as standarized extract of 0.3% Hypericin)
	5-Hydroxy-tryptophan	10-150	mg	50	mg
	(as seed extract of Griffonia simplificolia)
				350	mg	35-1050	mg
Formula	Hypericum perfoliatum	50-900	mg	300	mg
	(as standarized extract of 0.3% Hypericin)
	Eleutherococcus senticosus	200-3000	mg	1000	mg
				1300	mg	130-3900	mg
Formula	Rhodiola rosea	50-1000	mg	250	mg
	5-Hydroxy-tryptophan	100	mg	50	mg
	(as seed extract of Griffonia simplificolia)
	Panax Ginseng	0.5-3	g	1000	mg
				1300	mg	130-5200	mg
	Promethazine HCl	10-100	mg	5	mg
	Dexchlorpheneramine mal.	2-8	mg	1	mg
	Mepyramine maleate	25-100	mg	5	mg
	Prednisone	5-20	mg	1	mg
	Betamethasone	0.5-4.5	mg	0.1	mg
	Propanolol HCl	10-480	mg	10	mg
	Atenelol HCl	50-100	mg	50	mg
	Sotalol HCl	160-320	mg	80	mg
	Captopril	25-150	mg	10	mg
	Enalapril maleate	2.5-20	mg	2.5	mg
	Losartan	5-20	mg	1	mg
	Verapamil HCl	40-360	mg	20	mg
	Nifedipine	20-40	mg	5	mg
	Glibenclamide	2.5-15	mg	5	mg
	Chlorpropramide	100-500	mg	100	mg
	Gliclazide	80-320	mg	80	mg

Metformin HCl

0.5 g-3 g

250

mg

Salbutamol

200-1600

mcg

200

mcg

	Fenoterol HBr	2.5 mg-15 mg	2.5	mg
	Hexoprenaline	0.5 mg-1.5 mg	0.5	mg

Amoxicillin trihydrate	750-1500	mg	250	mg
Ampicillin trihydrate	1000-2000	mg	250	mg
Cloxacillin sodium	500-2000	mg	500	mg
Cephradine	1000-2000	mg	250	mg
Cephalexin monohydrate	1000-4000	mg	250	mg
Cefaclor	750-1500	mg	375	mg
Cefpodoxime	200-400	mg	100	mg
Erythromycin stearate	1000-4000	mg	250	mg
Ibuprofen	0.6-1.2	g	200	mg
Indomethacin	50-150	mg	25	mg
Mefenamic acid	500-1500	mg	250	mg
Naproxen	250-750	mg	250	mg
Acetylsalycillic acid	0.3-4	g	250	mg

Name/Substance/

Compound/Active Ingredient

1. A smoker's requisite which includes a carrier and a substance which is a combination of one or more of the following:

a tryptamine derivative;

a protein;

a steroid;

a statin;

a sulphonamide;

a substituted indole;

a substituted imidazole;

a metal-containing compound; and

an anti-depressants;

the substance being embodied in the carrier such that, when the requisite is lit and smoked by a smoker, a quantity of the substance is ingested by the smoker.

2. The smoker's requisite according to claim 1 wherein the tryptamine derivative is selected from any one, or any combination of serotonin and melatonin.

3. The smoker's requisite according to claim 1 wherein the protein is selected from any one, or any combination of endostatin and angiostatin.

4. The smoker's requisite according to claim 1 wherein the steroid is a steroidal anti-inflammatory compound.

5. The smoker's requisite according to claim 1 wherein the statin selected from any one, or any combination of lovastatin, simvastatin and pravastatin.

6. The smoker's requisite according to claim 1 wherein the sulphonamide is nimesulide.

7. The smoker's requisite according to claim 1 wherein the substituted indole is Iodine (etodolac).

8. The smoker's requisite according to claim 1 wherein the substituted imidazole is dacarbazine.

9. The smoker's requisite according to claim 1 wherein the metal-containing compound is selected from any one, or any combination of cisplatin and selenium compounds.

10. The smoker's requisite according to claim 1 wherein the anti-depressant is selected from any one, or any combination of the following: monoamine oxidase inhibitors selected from the hydrazine derivatives, isocarboxazid, phenelzine, nialamide, iproniazid and mebanzine, and the non-hydrazine monoamine oxidase inhibitors selected from pargyline, the tricyclic anti-depressants dibenzazepine, the zocyclohepetene derivatives amitriptyline, butriptyline, desipramine, clomipramine, protriptyline, nortriptyline, opipramol, trimipramine iprindole, and the tetracyclics maprotiline and mianserin.